Culture of Health Prize Johnson (Robert Wood) Foundation

landd125x125B_thumb.jpg 01-Nov-2018 25,000.00 USD
Contact Telephone 608-263-6983
Contact Email prize@match.wisc.edu
Sponsor Website https://www.rwjf.org/en/library/features/culture-of-health-prize.html
Program URL https://www.rwjf.org/en/library/funding-opportunities/2018/2019-rwjf-culture-of-health-prize.html
Deadline Dates (ALL) 01-Nov-2018
Synopsis The Robert Wood Johnson Foundation (RWJF) Culture of Health Prize (the Prize) recognizes communities that have come together around a commitment to health, opportunity, and equity through collaboration and inclusion, especially with historically marginalized populations and those facing the greatest barriers to good health.
Advertisements
| Leave a comment

Standard Research Grants American Foundation for Suicide Prevention

black-landd.jpg 15-Nov-2018 100,000.00 USD
Contact Telephone 212-363-3500
Contact Email grantsmanager@afsp.org
Sponsor Website https://afsp.org/our-work/research/grant-information/
Program URL http://afsp.org/wp-content/uploads/2018/06/Standard-Research-Policy-07-01-18.doc
Deadline Dates (ALL) 15-Nov-2018
Synopsis The American Foundation for Suicide Prevention (AFSP) provides grants for many different types of studies, including: psychiatry, medicine, psychology, genetics, epidemiology, neurobiology, sociology, nursing, social work, health services administration and many others.
| Leave a comment

Renewable Energy Systems and Energy Efficiency Improvements Assistance Under the Rural Energy for America Program Rural Business – Cooperative Service/Department of Agriculture

black-landd.jpg 31-Oct-2018 0.00 USD
Contact Email anthony.crooks@wdc.usda.gov
Sponsor Website https://www.gpo.gov/fdsys/pkg/FR-2018-08-14/html/2018-17513.htm
Deadline Dates (ALL) 31-Oct-2018, 01-Apr-2019
Synopsis  

Rural Business – Cooperative Service invites applications from agricultural producers and rural small businesses for renewable energy system and energy efficiency improvement projects to purchase and install renewable energy systems and make energy efficiency improvements to their operations.

| Leave a comment

Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) (Defunct) National Institute of Mental Health/NIH/DHHS

black-landd.jpg PAR-18-894 06-Dec-2018 0.00 USD
Contact Name Christopher Sarampote, Ph.D.
Contact Telephone 301-443-1959
Contact Email csarampo@mail.nih.gov
Program URL https://grants.nih.gov/grants/guide/pa-files/PAR-18-894.html
Deadline Dates (ALL) 06-Apr-2021, 06-Dec-2018, 07-May-2019, 09-Apr-2019, 07-Dec-2020, 07-Sep-2020, 07-May-2020, 07-Apr-2020, 07-Sep-2019, 06-Aug-2019, 07-Jan-2019, 07-Jan-2021, 06-Dec-2019, 07-Jan-2020, 06-Aug-2020
Synopsis  

National Institute of Mental Health (NIMH) invites applications for dissertation awards in all research areas within the strategic priorities of the NIMH to individuals from groups underrepresented in biomedical, behavioral, clinical and social sciences research. This award supports the completion of the doctoral research project. This FOA will utilize the NIH R36 Dissertation Award award mechanism.

| Leave a comment

Eugene Washington PCORI Engagement Awards: Capacity Building Patient-Centered Outcomes Research Institute (PCORI)

black-landd.jpg 01-Oct-2018 [LOI/Pre-App] 250,000.00 USD
Contact Telephone 202-370-9312
Contact Email ea@pcori.org
Sponsor Website https://www.pcori.org/funding-opportunities
Program URL https://www.pcori.org/funding-opportunities/announcement/engagement-award-capacity-building
Deadline Dates (ALL) 01-Oct-2018 [LOI/Pre-App]
Synopsis The Patient-Centered Outcomes Research Institute (PCORI) plans to award $20.5 million in fiscal year 2018 as part of the Eugene Washington PCORI Engagement Awards. These awards are for research support rather than a research funding opportunity. The Eugene Washington PCORI Engagement Awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research (PCOR/CER) enterprise.
| Leave a comment

NIH Program Announcements

black-landd.jpg

  • Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
    (PA-18-891)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt/Submission Date(s): November 1, 2018; May 30, 2019; October 31, 2019; June 2, 2020; November 3, 2020; June 1, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
    (PAR-18-892)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
    (PAR-18-893)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)
    (PAR-18-894)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): December 06, 2018, April 09, 2019, August 06, 2019, December 06, 2019, April 07, 2020, August 06, 2020, December 07, 2020, April 06, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)
    (PAR-18-895)
    National Institute of Allergy and Infectious Diseases
    National Institute of Mental Health
    Application Receipt/Submission Date(s): January 7, 2019; January 7, 2020; January 7, 2021, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
  • NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
    (PAR-18-896)
    National Library of Medicine
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
    (PAR-18-898)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt/Submission Date(s): November 1, 2018; May 30, 2019; October 31, 2019; June 2, 2020; November 3, 2020; June 1, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
    (PAR-18-899)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt/Submission Date(s): October 4, 2018; July 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
    (PAR-18-900)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt/Submission Date(s): October 4, 2018; July 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
| Leave a comment

NIH Requests for Applications

L-&-D_logo.30

  • Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)
    (RFA-AG-19-020)
    National Institute on Aging
    National Heart, Lung, and Blood Institute
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): December 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)
    (RFA-CA-18-012)
    National Cancer Institute
    Application Receipt Date(s): November 15, 2018, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date. No late application will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)
    (RFA-CA-19-017)
    National Cancer Institute
    Application Receipt Date(s): January 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Human Islet Research Network – Consortium on Human Islet Biomimetics (HIRN-CHIB) (UG3/UH3 Clinical Trial Not Allowed)
    (RFA-DK-18-011)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): December 11,2018, by 5:00 PM local time of applicant organization.
  • NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37)
    (RFA-MD-18-007)
    National Institute on Minority Health and Health Disparities
    John E. Fogarty International Center
    Application Receipt Date(s): October 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
    (RFA-MH-19-240)
    National Institute of Mental Health
    Application Receipt Date(s): November 20, 2018; November 20, 2019; November 20, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this funding opportunity announcement.
  • Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection (U01 Clinical Trial Not Allowed)
    (RFA-NS-18-033)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): December 13, 2018, by 5:00PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection – Coordinating Center (U24 Clinical Trial Not Allowed)
    (RFA-NS-18-034)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): December 13, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on ?this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed)
    (RFA-RM-18-026)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed)
    (RFA-RM-18-027)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)
    (RFA-RM-18-028)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed)
    (RFA-RM-18-036)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed)
    (RFA-RM-18-037)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
| Leave a comment